Literature DB >> 7352876

Juvenile fibromatosis of the periorbital region and eyelid. A clinicopathologic study of six cases.

A A Hidayat, R L Font.   

Abstract

Six cases of juvenile fibromatosis of the periorbital region and eyelid were studied. The median age of the patients was 8 years (range, 1 to 11 years). A definite propensity for involvement of the infraorbital region and lower eyelid was observed. THREE TUMORS EXHIBITED A PROMINENT LOBULAR PATTERN AND WERE ADHERENT TO THE PERIOSTEUM. The main entities in the differential diagnosis included leiomyoma, neurofibroma, and well-differentiated fibrosarcoma. Two of six tumors recurred locally but did not metastasize. Electron microscopic studies disclosed that the spindle-shaped tumor cells exhibited features of fibroblasts. It appears that conservative treatment (ie, local excision) is adequate.

Entities:  

Mesh:

Year:  1980        PMID: 7352876     DOI: 10.1001/archopht.1980.01020030276007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

Review 1.  Orbital infantile myofibroma: a case report and clinicopathologic review of 24 cases from the literature.

Authors:  Corey J Mynatt; Kenneth A Feldman; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2011-04-22

Review 2.  Juvenile fibromatosis of the orbit: a case report with review of the literature.

Authors:  R J Campbell; J A Garrity
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

3.  Adult periorbital fibromatosis.

Authors:  C N Smoot; G B Krohel; R S Smith
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

Review 4.  Orbital involvement in multifocal fibrosclerosis.

Authors:  G W Aylward; T J Sullivan; A Garner; I Moseley; J E Wright
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

5.  Clinicopathological study of three cases of infantile fibromatosis of the orbit.

Authors:  Kengo Hayashi; Nobutada Katori; Yoshiro Otsuki; Kyoko Ohno-Matsui
Journal:  Int Ophthalmol       Date:  2014-02-15       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.